| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.31 | 5e-14 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.35 | 2e-11 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.37 | 9e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |